Using SystemCHANGE™ to Enhance Medication Adherence in Older Adult Stroke Survivors

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

November 28, 2017

Primary Completion Date

February 6, 2018

Study Completion Date

May 24, 2018

Conditions
Stroke, Ischemic
Interventions
BEHAVIORAL

SystemCHANGE™

During the intervention phase, the PI will visit both groups of participants at home at baseline and telephone them three times (day 3 ±2 days and months 1 and 2). Refer to tables 1 and 2 for intervention details. Treatment participants will implement SystemCHANGE™ activities related to medication taking with the assistance of the PI while attention-control participants will receive patient education materials on stroke. Perceived health data will be collected during the intervention phase. A 1-month maintenance phase follows the intervention phase. Electronic medication monitoring continues, but no intervention is delivered to either group.

BEHAVIORAL

Attention-Control

An experienced stroke nurse will deliver the attention control intervention. Table 3.2 shows the 2-month attention-control intervention. The stroke materials were developed by the Saint Luke's Marion Bloch Neuroscience Institute and are given to every stroke patient prior to dismissal. The PI will call participants at day 3 ±2 days, and months 1 and 2 to review chapter(s) from the book and answer questions about it. Interval, frequency, and setting are all exactly the same for the intervention and control groups. If the control participant raises questions about medications or medication-taking, PI will refer them to their Neurologist.

Trial Locations (1)

64152

Jennifer Wessol, Parkville

All Listed Sponsors
collaborator

Saint Luke's Health System

OTHER

lead

University of Missouri, Kansas City

OTHER

NCT03211130 - Using SystemCHANGE™ to Enhance Medication Adherence in Older Adult Stroke Survivors | Biotech Hunter | Biotech Hunter